Correlation Between Scilex Holding and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scilex Holding and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scilex Holding and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scilex Holding and Pfizer Inc, you can compare the effects of market volatilities on Scilex Holding and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scilex Holding with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scilex Holding and Pfizer.

Diversification Opportunities for Scilex Holding and Pfizer

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Scilex and Pfizer is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Scilex Holding and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Scilex Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scilex Holding are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Scilex Holding i.e., Scilex Holding and Pfizer go up and down completely randomly.

Pair Corralation between Scilex Holding and Pfizer

Assuming the 90 days horizon Scilex Holding is expected to generate 12.36 times more return on investment than Pfizer. However, Scilex Holding is 12.36 times more volatile than Pfizer Inc. It trades about 0.06 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.06 per unit of risk. If you would invest  36.00  in Scilex Holding on September 3, 2024 and sell it today you would lose (7.00) from holding Scilex Holding or give up 19.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.31%
ValuesDaily Returns

Scilex Holding  vs.  Pfizer Inc

 Performance 
       Timeline  
Scilex Holding 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Scilex Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Scilex Holding showed solid returns over the last few months and may actually be approaching a breakup point.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Scilex Holding and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scilex Holding and Pfizer

The main advantage of trading using opposite Scilex Holding and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scilex Holding position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Scilex Holding and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
CEOs Directory
Screen CEOs from public companies around the world